A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
Clinical trial NCT00316602 · COMPLETED
Trial details
- NCT number
- NCT00316602
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-11-01
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.